Scripps miRNA flips HER2-negative tumors to HER2-positive

Researchers at the Scripps Research Institute developed a dimeric small molecule that can switch on HER2 in cancers cells where it was previously not up-regulated, sensitizing HER2-negative breast cancer and

Read the full 300 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE